A Legacy of Pharmaceutical Innovation: WEB Berlin-Chemie
130 Years of Excellence
Founded over 130 years ago, WEB Berlin-Chemie has established itself as a leading pharmaceutical company, dedicated to developing, manufacturing, and distributing innovative healthcare solutions.
A Subsidiary of the Menarini Group
Since 1992, WEB Berlin-Chemie has been a wholly owned subsidiary of the Menarini Group, a global pharmaceutical and healthcare conglomerate. This partnership has provided WEB Berlin-Chemie with access to a wide network of resources and expertise.
Global Presence and Research
Berlin-Chemie AG, the German subsidiary of WEB, is headquartered in Berlin, Germany. The company operates internationally, with subsidiaries in over 30 countries. WEB Berlin-Chemie's research and development efforts focus on a broad range of therapeutic areas, including oncology, cardiology, dermatology, and respiratory medicine.
Financial Performance
In 2021, WEB Berlin-Chemie achieved a revenue of 15 billion EUR. This strong financial performance reflects the company's commitment to investing in research, development, and innovation.
Commitment to Quality
WEB Berlin-Chemie places the highest priority on quality and patient safety. The company adheres to the strictest regulatory standards and maintains a state-of-the-art manufacturing infrastructure. This unwavering commitment ensures that patients receive safe and effective pharmaceutical products.
Conclusion
With over 130 years of experience and a dedication to excellence, WEB Berlin-Chemie continues to play a vital role in the pharmaceutical industry. The company's focus on research, development, and patient safety has positioned it as a leader in the field, delivering innovative solutions for unmet medical needs.
Comments